PaulEdwardGossMDMBBCh, Ph.D.

Clinical Trials

• Letrozole After Tamoxifen in Treating Women With Breast Cancer Start of enrollment: 1998 Aug 24

  Completed

  Phase 3

• Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer Start of enrollment: 2003 Jun 06

  Completed

  Phase 3

• Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer Start of enrollment: 2001 Aug 01

  Completed

  Not Applicable

• Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer Start of enrollment: 2004 Dec 03

  Completed

  Phase 3

• Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer Start of enrollment: 2005 Jan 26

  Completed

• Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density Start of enrollment: 2000 Dec 05

  Completed

  Phase 2

• Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer Start of enrollment: 2005 Oct 01

  Unknown status

  Phase 2

• Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole Start of enrollment: 2006 Apr 01

  Completed

• Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial Start of enrollment: 2006 Apr 24

  Completed

  Phase 3

• Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer Start of enrollment: 2007 Oct 01

  Terminated

  Phase 2

• Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3 Start of enrollment: 2008 Jul 10

  Completed

• Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy Start of enrollment: 2004 Nov 23

  Completed

  Phase 3

• Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17 Start of enrollment: 2006 Jun 01

  Unknown status

• Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy Start of enrollment: 2006 Aug 01

  Completed

• Join now to see all